Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 3/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17883165 | 0.86 | ALDH1A1 (0.35) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL2877093 | 0.80 | FAAH (0.35) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL22043190 | 0.80 | ALDH1A1 (0.38) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL24136122 | 0.80 | RIPK1 (0.31) | RIPK1 | |
| SCHEMBL5021619 | 0.79 | RIPK1 (0.52) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL6807345 | 0.78 | EPHX1 (0.53) | KMT2AALDH1A1EPHX1 | |
| SCHEMBL13765691 | 0.78 | ALDH1A1 (0.33) | RIPK1ALDH1A1 | |
| SCHEMBL14556928 | 0.78 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL1346149 | 0.78 | — | — | |
| SCHEMBL27383204 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230225147-A1 | ORGANIC LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230157149-A1 | ORGANIC-INORGANIC PEROVSKITE, FILM, LIGHT-EMITTING FILM, DELAYED FLUORESCENCE-EMITTING FILM, LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-11335872-B2 | Organic light-emitting device | KYULUX, INC. (JP) | 2022-05-17 | — | — | US | disclosed |
| US-20210234113-A1 | ORGANIC LIGHT-EMITTING DEVICE | KYULUX, INC. (JP) | 2021-07-29 | — | — | US | disclosed |
| US-20200343453-A1 | LIGHT-EMITTING MATERIAL, ORGANIC LIGHT-EMITTING ELEMENT, AND COMPOUND | Kyushu University, University Corporation (JP) | 2020-10-29 | — | — | US | disclosed |
| US-20170229658-A1 | ORGANIC LIGHT-EMITTING DEVICE | KYULUX, INC. (JP) | 2017-08-10 | — | — | US | disclosed |
| US-20160164000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160164000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND ORGANIC LIGHT EMITTING DEVICE | DRD1, DRD2, AAAS | MMP1 4740/4885MMP2 4839/4885MMP3 4621/4885 |
| US-20230157149-A1 | ORGANIC-INORGANIC PEROVSKITE, FILM, LIGHT-EMITTING FILM, DELAYED FLUORESCENCE-EMITTING FILM, LIGHT-EMITTING ELEMENT, AND METHOD FOR PRODUCING LIGHT-EMITTING ELEMENT | ECE1, ECE2, ESR1 | MMP1 2144/4885MMP2 4851/4885MMP3 3095/4885 |
| US-20170229658-A1 | ORGANIC LIGHT-EMITTING DEVICE | CCNE2, LAGE3, CRY2 | MMP1 4629/4885MMP2 4832/4885MMP3 2856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.